EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:755907 - satralizumab
| ChEBI ID | CHEBI:755907 |
| ChEBI Name | satralizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Application: | antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| satralizumab (CHEBI:755907) has role antihypertensive agent (CHEBI:35674) |
| satralizumab (CHEBI:755907) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| RG6168 | ChEMBL |
| SA-237 | ChEMBL |
| SA237 | ChEMBL |
| Sapelizumab | ChEMBL |
| Satralizumab | ChEMBL |
| Satralizumab mwge | ChEMBL |
| Brand Name | Source |
|---|---|
| Enspryng | ChEMBL |